Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

6 677 evidences · page 49 / 268

24,43 %In the 2015 Kenya STEPwise Survey, 24.43% of participants were classified as having hypertension.

Kenyahypertension artérielleobservé 2015publié 2021Public healthPubMeddocument de 7 observations

72 participants72 participants had multiple sexually transmitted infections (STIs) during follow-up.

Kenyasexually transmitted infection (STI)publié 2023The Journal of adolescent health : official publication of the Society for Adolescent MediPubMeddocument de 9 observations

64 %The incidence of hospitalized malaria from the same community was concentrated among children aged 6 months to 4 years, accounting for 64% of all hospitalized malaria during the 12 months of surveillance.

Kenyapaludismeobservé 12 monthspublié 2020Malaria journaleurope_pmcdocument de 5 observationsDOI 10.1186/s12936-020-03286-6

The FY.4 variant circulated as early as December 2022 in Kenya.

KenyaCOVID-19observé December 2022publié 2025Virus evolutioneurope_pmcdocument de 4 observations

97 %97% of reported adverse events were mild after yellow fever vaccination.

Kenyafièvre jaunepublié 2023The Lancet. Infectious diseasesPubMeddocument de 7 observations

86 %By 2018, the estimated percentage of adolescent girls and young women who would know their HIV status was 86% if all were DREAMS invitees and 56% if none were DREAMS invitees in Nairobi.

KenyaVIH/sidaobservé 2018publié 2022AIDS (London, England)PubMeddocument de 11 observations

19 %Among STI clients, 19% (10/52) tested positive for gonorrhoea (n = 7) and/or chlamydia (n = 5).

Kenyachlamydia · gonorrhoeapublié 2025Journal of the International AIDS SocietyPubMeddocument de 19 observations

1,47 odds_ratioThere was no significant association between diabetes control and occurrence of cervical cytomorphological abnormalities (odds ratio = 1.47, p = 0.704).

Kenyacervical cytomorphological abnormalities · diabète (non précisé)publié 2025Acta cytologicaPubMeddocument de 7 observations

13 %Overall compliance with the malaria test and treat policy was 13%.

Kenyapaludismeobservé April 2019publié 2020Malaria journaleurope_pmcdocument de 20 observations

28 daysBinding antibody levels peaked at day 28 after PCR testing.

KenyaCOVID-19publié 2023Wellcome open researcheurope_pmcdocument de 4 observations

2,3 HOMA-IR unitsThe median HOMA-IR was 2.3 (0.7, 6.5).

Kenyadiabète de type 2publié 2021Scientific reportsPubMeddocument de 7 observations

36,4 %The mutant pfmdr1 86Y/184Y/1246Y allele declined from 36.4% in 1995 to 0% in 2013 in Plasmodium falciparum from coastal Kenya.

Kenyapaludismeobservé 1995publié 2014International journal for parasitology. Drugs and drug resistanceeurope_pmcdocument de 4 observations

17,6 %The prevalence of fever among children under the age of five years was 17.6% in northern Namibia, based on the 2009 Malaria Indicator Survey.

Kenyafeverobservé 2009publié 2012International journal of health geographicseurope_pmcdocument de 2 observationsDOI 10.1186/1476-072x-11-6

9,1 %56 (9.1%) of the 617 participants were infected with non-tuberculous mycobacteria.

Kenyanon-tuberculous mycobacteriaobservé July 2021 to June 2022publié 2023Ethiopian journal of health sciencesPubMeddocument de 9 observations

1 hazard_ratioThe ratio of monocytes to lymphocytes shows no association with risk of clinical malaria during follow-up among Kenyan children without detectable parasitaemia.

Kenyapaludismepublié 2013PloS oneeurope_pmcdocument de 2 observations

3,75 aORAfter excluding women with concurrent bacterial vaginosis, concurrent vaginal Lactobacillus colonization was associated with an adjusted odds ratio of 3.75 for symptomatic vulvovaginal candidiasis (VVC).

Kenyavulvovaginal candidiasis (VVC)publié 2009The Journal of infectious diseaseseurope_pmcdocument de 5 observationsDOI 10.1086/599213

72,4 %Among 29 confirmed cases of endocervical adenocarcinoma diagnosed at AKUHN between July 2017 and July 2018, high-risk HPV type 16 was present alone or in combination with others including type 18 in 21 (72.4%) cases.

Kenyaendocervical adenocarcinomaobservé July 2017 to July 2018publié 2022Annals of clinical and laboratory sciencePubMeddocument de 5 observations

68 patientsEMR data included 68 patients with NCD from Kakuma's surgical and outpatient departments.

Kenyanoncommunicable diseaseobservé May 2021 to March 2022publié 2023JMIR mHealth and uHealthPubMeddocument de 10 observations

0,5 %Among 1265 participants with complete data on HBsAg and HBcAb-Total, 0.5% had acute HBV infection.

Kenyahépatite Bpublié 2023PloS onePubMeddocument de 15 observations

15 000 mosquitoesThe Kenyan national malaria program analyses an average of 15,000 mosquitoes annually.

Kenyapaludismepublié 2025PloS onePubMeddocument de 5 observations

184 eventsFrom week 3 through week 26, a total of 184 events of hospital readmission or death occurred in the dihydroartemisinin-piperaquine chemoprevention group and 316 occurred in the placebo group.

Kenyasevere anemiapublié 2020The New England journal of medicinePubMeddocument de 5 observations

The Mobile WAChX trial evaluates an interactive semiautomated SMS text messaging intervention to improve adherence to antiretroviral therapy and retention in care among peripartum women infected with HIV in Kenya.

KenyaVIH/sidapublié 2020JMIR mHealth and uHealthPubMeddocument de 12 observations

60 %The 5-year relative survival for prostate cancer patients in sub-Saharan Africa was 60.0%.

Kenyacancer de la prostateobservé 2005-2015publié 2021Cancer causes & control : CCCeurope_pmcdocument de 7 observationsDOI 10.1007/s10552-021-01453-x

27 %PLHIV had a 27% higher mean hsCRP concentration compared with HIV-negative participants, independent of CVD risk factors.

KenyaVIH/sidapublié 2021Clinical infectious diseases : an official publication of the Infectious Diseases Society PubMeddocument de 8 observations

51,2 %Of the 168 widows with confirmed dates of HIV diagnosis, 51.2% may have been exposed 2 years after widowhood.

KenyaVIH/sidapublié 2026Global health actioneurope_pmcdocument de 5 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.